Treos Bio
Develops peptide-based cancer immunotherapies for patients and pharmaceutical development partners
Highlights
- New on EvolcAdded 2026-11-01
About Treos Bio
Treos Therapeutics develops computationally designed peptide immunotherapies, including off-the-shelf and personalized cancer treatments. Its lead candidate, PolyPEPI1018, is an off-the-shelf peptide immunotherapy for colorectal cancer.
The company also develops companion diagnostic tools to identify likely responders and describes co-development opportunities for its products. It has a preventive peptide immunotherapy program for COVID-19.
Treos Bio Limited was founded in 2016 and is headquartered in London. The company reports clinical trials of its lead product and equity financing.
Product: Computationally designed peptide immunotherapies for cancer and infectious diseases, with companion diagnostic tools.
Jobs at Treos Bio
Leadership
- Enikő R. Tőke · Chief Scientific Officer, DirectorSource: company website
- Sunjeet Sawhney · Chief Executive OfficerSource: company website
- Gábor Illés · Chief Financial Officer, DirectorSource: company website
- Levente Molnár · Head of BioinformaticsSource: company website
More biotech & pharma companies
Trimtech Therapeutics
Develops small-molecule protein degraders for Alzheimer's, Parkinson's and other neurodegenerative and inflammatory diseasesYoung companyNew on EvolcVeramed
Clinical trial biometrics services (data management, biostatistics, programming) for pharma and biotech sponsorsNew on EvolcVerdiva Bio
Develops once-weekly peptide medicines for obesity and cardiometabolic disease, with a lead drug in Phase 2 trialsYoung companyNew on EvolcWaymade PLC
Specialty pharmaceutical company developing, licensing and commercialising generic and niche medicines for patients worldwideNew on EvolcWellcome
Charitable foundation funding biomedical research on health challenges and running a free museum and library in LondonNew on EvolcRemote-friendlySalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.